BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7556338)

  • 1. Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy.
    Kobayashi I; Nakanishi M; Okano M; Sakiyama Y; Matsumoto S
    Eur J Pediatr; 1995 Jul; 154(7):594-5. PubMed ID: 7556338
    [No Abstract]   [Full Text] [Related]  

  • 2. A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy.
    Satake N; Nakanishi M; Okano M; Tomizawa K; Ishizaka A; Kojima K; Onodera M; Ariga T; Satake A; Sakiyama Y
    Eur J Pediatr; 1993 Apr; 152(4):313-5. PubMed ID: 8482279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506).
    Bousvaros A; Leichtner AM; Book L; Shigeoka A; Bilodeau J; Semeao E; Ruchelli E; Mulberg AE
    Gastroenterology; 1996 Jul; 111(1):237-43. PubMed ID: 8698205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.
    Assmann T; Ruzicka T
    Clin Dermatol; 2002; 20(5):505-14. PubMed ID: 12435521
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of severe refractory adult autoimmune enteropathy with infliximab and tacrolimus.
    von Hahn T; Stopik D; Koch M; Wiedenmann B; Dignass A
    Digestion; 2005; 71(3):141-4. PubMed ID: 15785040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus use in renal and cardiac pediatric transplantation: no increased risk of food allergies.
    Graham F; Racicot F; Jamali L; Cong VP; Raboisson MJ; Paradis J; Paradis L; Des Roches A
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):155-7. PubMed ID: 26094803
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity.
    Klein IH; Abrahams AC; van Ede T; Oey PL; Ligtenberg G; Blankestijn PJ
    J Hypertens; 2010 Sep; 28(9):1928-34. PubMed ID: 20577127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT.
    Oshima K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Kanda Y
    Bone Marrow Transplant; 2010 Apr; 45(4):781-2. PubMed ID: 19701249
    [No Abstract]   [Full Text] [Related]  

  • 9. A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy.
    Kobayashi I; Imamura K; Yamada M; Okano M; Yara A; Ikema S; Ishikawa N
    Clin Exp Immunol; 1998 Mar; 111(3):527-31. PubMed ID: 9528893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide.
    Oliva-Hemker MM; Loeb DM; Abraham SC; Lederman HM
    J Pediatr Gastroenterol Nutr; 2003 May; 36(5):639-43. PubMed ID: 12717089
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient.
    Ko WJ; Lin FL; Wang SS; Chu SH
    J Heart Lung Transplant; 1997 Sep; 16(9):980-2. PubMed ID: 9322151
    [No Abstract]   [Full Text] [Related]  

  • 12. Adult autoimmune enteropathy treated successfully with tacrolimus.
    Daum S; Sahin E; Jansen A; Heine B; Riecken EO; Zeitz M; Schmidt W
    Digestion; 2003; 68(2-3):86-90. PubMed ID: 14581765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune enteropathy in a child: response to infliximab therapy.
    Vanderhoof JA; Young RJ
    J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):312-6. PubMed ID: 11964960
    [No Abstract]   [Full Text] [Related]  

  • 14. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
    Jensen GS; Wiseman A; Trotter JF
    Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study.
    Doesch AO; Mueller S; Konstandin M; Celik S; Erbel C; Kristen A; Frankenstein L; Koch A; Dengler TJ; Ehlermann P; Zugck C; De Geest S; Katus HA
    Transplant Proc; 2010 Dec; 42(10):4238-42. PubMed ID: 21168673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical tacrolimus in dermatology: what can one expect?].
    Lacour JP
    Ann Dermatol Venereol; 2001 Dec; 128(12):1291-4. PubMed ID: 11908129
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autoimmune enteropathy in children].
    Moes ND; Ruemmele FM; Rings EH
    Ned Tijdschr Geneeskd; 2011; 155():A3246. PubMed ID: 21527058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
    Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
    Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Effect of 0.1% Topical Tacrolimus for Childhood Interstitial Keratitis Refractory to Cyclosporine.
    Joko T; Shiraishi A; Ogata M; Ohashi Y
    J Nippon Med Sch; 2016; 83(1):31-4. PubMed ID: 26960587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.
    Falkenstein K; Dunn S
    Transplant Proc; 1998 Aug; 30(5):1964-6. PubMed ID: 9723354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.